Industry News

Industry News
It is an exciting time at ARx. We are continuously expanding our team, technologies, and capabilities. Check back for ARx in the news, corporate updates, and where to find us at industry events.
December 10, 2019
July 28, 2019
The ARx team is busy in early November. Our R&D and Engineering team are attending AAPS PharmSci360 in San Antonio, TX, November 3-6, 2019. Contact Eric […]
July 28, 2019
Contact ARx to set up a meeting at the largest pharmaceutical conference in the world, CPhI Worldwide in Frankfurt Germany! November 5-7, 2019. We are available […]
July 1, 2019
Being focused on specific dosage forms such as transdermal patches and mucosal thin films allows ARx to understand the trends in development and commercial markets. We […]
October 29, 2018
ARx is excited to present its poster, “Comparative Permeation Study of A Novel Buprenorphine Transmucosal Dosage Form versus Sublingual Tablet & Buccal Film” at AAPS Pharm […]
July 23, 2018
ARx partners with Clients to develop novel drug products with specific delivery objectives such as rapid onset, controlled release, and avoidance of the first pass metabolism. […]
July 23, 2018
ARx Research Scientist, William Baer, MS presented Dissolution Testing of a Fast-Dissolving Oral Vardenafil Free Base Film at the American Association of Pharmaceutical Scientists Show in […]
July 23, 2018
Quality by Design is well known in the pharmaceutical industry. It is the initiative curated by the Food and Drug Administration (FDA) to ensure that the […]
July 23, 2018
2018 has been busy for ARx thus far. We are proud to have participated in two major industry events, showcasing how our technology advancements are leading […]
January 22, 2018
The US Food and Drug Administration (FDA) approved its last novel drug of 2017, Giaprezaon to increase blood pressure in adults with septic or other distributive […]
February 13, 2017
With over 35 years experience in the transdermal industry, no one understands adhesive selection for transdermal patches better than ARx, LLC. and Adhesives Research Inc. The criticality […]
February 13, 2017
Originally published in 2012 by ARx Technical Director, Scott Barnhart, this article speaks to relevant challenges and benefits seen in the drug market today, specifically, the possibilities and benefits of mucosal thin […]
February 3, 2017
Attend one of the largest global meetings for accelerating drugs to market and lengthening product lifecycles for long term profitability. Schedule a meeting with ARx‘s Business Development Team […]
February 3, 2017
On March 20th-23rd, the Drug, Chemical, and Associated Technologies Association takes over Midtown East, Manhattan for thousands of business meetings and networking opportunities. Schedule a meeting with […]